[Zrytec drops in the treatment of allergy rhinitis in children].
OBJECTIVE
To assess the efficacy and safety of Zyrtec drops which is a patent product of UCB pharma in treatment of allergy rhinitis in children.


METHODS
A total of 47 children of both sexes aged between 2 to 6 years with allergy rhinitis (AR) were included in this study, who were randomly selected to be treated with Zyrtec (Cetirizine 2 HCL) drops 5 mg daily for 3 weeks. Investigators made a global evaluation with symptom scores before treatment and once a week for 3 weeks after treatment.


RESULTS
An improvement was shown in each week after treatment with statistical significance (P < 0.01). Zyrtec drops provided an excellent improvement at the end of the study. Tolerance was good.


CONCLUSIONS
For acting fast, potent, good tolerance and convenience in use, Zyrtec drops is a better treatment in AR in kids.
Tang
J Y
JY
Ninth People's Hospital, Shanghai 200011.
D017332:Cetirizine / Q000008:administration & dosage* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy*
D039563:Histamine H1 Antagonists, Non-Sedating; D017332:Cetirizine